Overview

High-Volume Image-Guided Injection in Chronic Midportion Achilles Tendinopathy

Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
Overuse injury of the Achilles tendon is a common entity in athletes. Currently, the usual treatment for chronic midportion Achilles tendinopathy is an eccentric exercise program. In most cases this gives satisfactory results, however there is a significant group of patients in which the exercise program is not sufficient. Prior to our study, three United Kingdom based studies have investigated the efficacy of High-Volume Image-Guided Injections (HVIGI's) in chronic midportion Achilles tendinopathy. They all showed promising results. However none of these studies had an adequate control group. This double-blind, placebo-controlled, randomized clinical trial will investigate the value of a High-Volume Image-Guided Injection in chronic midportion Achilles tendinopathy.
Phase:
Phase 4
Details
Lead Sponsor:
Erasmus Medical Center
Collaborators:
Dutch Arthritis Association
The Anna Foundation
Treatments:
Lidocaine
Pharmaceutical Solutions